These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9563814)

  • 21. Long-term observations on the clinical use of lamotrigine as add-on drug in patients with epilepsy.
    Cocito L; Maffini M; Loeb C
    Epilepsy Res; 1994 Oct; 19(2):123-7. PubMed ID: 7843167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The use of lamotrigine, vigabatrin and gabapentin as add-on therapy in intractable epilepsy of childhood.
    McDonald DG; Najam Y; Keegan MB; Whooley M; Madden D; McMenamin JB
    Seizure; 2005 Mar; 14(2):112-6. PubMed ID: 15694564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lamotrigine treatment of 92 patients with intractable epilepsy].
    Karlsborg M; Gram L; Dam M
    Ugeskr Laeger; 1996 Apr; 158(14):1969-72. PubMed ID: 8650771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamotrigine adjunctive therapy in children with refractory epilepsy: a medical center study.
    Chen SJ; Chang KP; Wong TT; Kwan SY; Hsu ML; Wang CC
    Acta Paediatr Taiwan; 2006; 47(3):123-6. PubMed ID: 17078464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Optimal use of lamotrigine in clinical practice: results of an open multicenter trial in refractory epilepsy].
    Arzimanoglou A; Kulak I; Bidaut-Mazel C; Baldy-Moulinier M
    Rev Neurol (Paris); 2001 May; 157(5):525-36. PubMed ID: 11438772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epilepsy treatment in Rett syndrome.
    Krajnc N; Župančič N; Oražem J
    J Child Neurol; 2011 Nov; 26(11):1429-33. PubMed ID: 21636780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lamotrigine in children with refractory epilepsy.
    Celebi A; Yalnmzoğlu D; Turanli G; Topaloğlu H; Aysun S; Topçu M
    Turk J Pediatr; 2008; 50(5):426-31. PubMed ID: 19102045
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lamotrigine can be beneficial in patients with Dravet syndrome.
    Dalic L; Mullen SA; Roulet Perez E; Scheffer I
    Dev Med Child Neurol; 2015 Feb; 57(2):200-2. PubMed ID: 25243660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurophysiologic and neuropsychologic profiles of lamotrigine in epilepsy.
    Marciani MG; Spanedda F; Mattia D
    Clin Neuropharmacol; 1999; 22(3):159-63. PubMed ID: 10367180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
    Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
    Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is there a lamotrigine withdrawal syndrome?
    Gelisse P; Kissani N; Crespel A; Jafari H; Baldy-Moulinier M
    Acta Neurol Scand; 2002 Mar; 105(3):232-4. PubMed ID: 11886370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double-blind, placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy.
    Beran RG; Berkovic SF; Dunagan FM; Vajda FJ; Danta G; Black AB; Mackenzie R
    Epilepsia; 1998 Dec; 39(12):1329-33. PubMed ID: 9860069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lamotrigine in typical absence epilepsy.
    Buoni S; Grosso S; Fois A
    Brain Dev; 1999 Jul; 21(5):303-6. PubMed ID: 10413016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lamotrigine. A review of its use in childhood epilepsy.
    Culy CR; Goa KL
    Paediatr Drugs; 2000; 2(4):299-330. PubMed ID: 10946418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction.
    Pisani F; Oteri G; Russo MF; Di Perri R; Perucca E; Richens A
    Epilepsia; 1999 Aug; 40(8):1141-6. PubMed ID: 10448829
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lamotrigine in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
    Bootsma HP; Vos AM; Hulsman J; Lambrechts D; Leenen L; Majoie M; Savelkoul M; Schellekens A; Aldenkamp AP
    Epilepsy Behav; 2008 Feb; 12(2):262-8. PubMed ID: 18093878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group.
    Brodie MJ; Overstall PW; Giorgi L
    Epilepsy Res; 1999 Oct; 37(1):81-7. PubMed ID: 10515178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion from immediate-release to extended-release lamotrigine improves seizure control.
    Ramey P; Osborn M; Abou-Khalil B
    Epilepsy Res; 2014 Nov; 108(9):1637-41. PubMed ID: 25205163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In children with refractory epilepsy: vigabatrin or lamotrigine?].
    Caviedes BE; Herranz JL; Arteaga R; Armijo JA
    Rev Neurol; 1999 Mar 1-15; 28(5):444-8. PubMed ID: 10229954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lamotrigine as add-on therapy in adult patients with refractory epilepsy.
    Yen DJ; Yiu CH; Kwan SY; Lin YY; Su MS
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 May; 59(5):303-7. PubMed ID: 9248123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.